INS and Hepatic steatosis: The total daily insulin doses and the proportion of those treated with antihypertensive medications (i.e., diuretics, beta-blockers, calcium-channel blockers, or renin-angiotensin system inhibitors), antiplatelet or lipid-lowering agents were also higher in patients with hepatic steatosis and significant fibrosis.